Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-26-000065·Quoin Pharmaceuticals, Ltd.
Schedule 13G ownership disclosure
QUOIN PHARMACEUTICALS LTD
Ordinary Shares · CUSIP: 74907L409
Event date: 2026-01-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Stonepine Capital Management, LLC
Shares: 3,271,100.00 · Class: 10.6%
- Stonepine Capital, L.P.
Shares: 3,271,100.00 · Class: 10.6%
- Stonepine GP, LLC
Shares: 3,271,100.00 · Class: 10.6%
- Jon M. Plexico
Shares: 3,271,100.00 · Class: 10.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-26-000065
- Form type
- SCHEDULE 13G/A
- Filer
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK 1671502
- Filed
- Feb 02, 2026
- Reporting period
- Jan 29, 2026
- Description
- Schedule 13G beneficial ownership